Comparison

Pteryxin European Partner

Item no. TMO-T5S1408-50mg
Manufacturer TargetMol
CASRN 13161-75-6
Amount 50 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 98.94%
Citations Orhan, I., Senol, F., Shekfeh, S., Skalicka-Wozniak, K., & Banoglu, E. (2017). Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea.?Food And Chemical Toxicology,?109, 970-974. doi: 10.1016/j.fct.2017.03.016
Smiles C\C=C(\C)C(=O)O[C@H]1[C@@H](OC(C)=O)C(C)(C)Oc2ccc3ccc(=O)oc3c12
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias (+)-Pteryxin
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cholinesterase (ChE)
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
386.4
Description
(+)-Pteryxin ((+)-Pteryxin) has muscle-relaxant props. (+)-Pteryxin shows hepatoprotective and nitric oxide prodn. inhibitory activity.
Pathways
Neuroscience

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close